Drug Quality and Security Act
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legislation
|
| gptkbp:addresses |
counterfeit drugs
|
| gptkbp:aims_to |
drug supply chain security
|
| gptkbp:amended_by |
gptkb:Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:enacted_by |
gptkb:legislation
November 27, 2013 |
| gptkbp:enhances |
drug quality standards
|
| gptkbp:established |
track and trace system
|
| gptkbp:facilitates |
information sharing among stakeholders
|
| https://www.w3.org/2000/01/rdf-schema#label |
Drug Quality and Security Act
|
| gptkbp:includes |
wholesaler licensing requirements
|
| gptkbp:influence |
penalties for violations
|
| gptkbp:is_part_of |
gptkb:Drug_Supply_Chain_Security_Act
|
| gptkbp:provides |
interstate commerce regulations
|
| gptkbp:requires |
serialization of prescription drugs
|
| gptkbp:signed_by |
gptkb:President_Barack_Obama
|
| gptkbp:supports |
patient safety initiatives
|
| gptkbp:bfsParent |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
gptkb:U._S._Food_and_Drug_Administration |
| gptkbp:bfsLayer |
4
|